Late-onset blueberry muffin lesions following recombinant erythropoietin administration in a premature infant

Vishal Pandey, Krishna Dummula, Garth Fraga, Prabhu Parimi

Research output: Contribution to journalArticlepeer-review

Abstract

Recombinant erythropoietin is being used in premature population for anemia of prematurity. It is considered very safe in this population, although risks are still being evaluated. We report the first case of dermal erythropoiesis as a side effect of recombinant erythropoietin in an extremely prematurely born infant presenting with late-onset blueberry muffin lesions.

Original languageEnglish (US)
Pages (from-to)534-535
Number of pages2
JournalJournal of Pediatric Hematology/Oncology
Volume34
Issue number7
DOIs
StatePublished - Oct 1 2012
Externally publishedYes

Keywords

  • anemia of prematurity
  • dermal erythropoiesis
  • extramedullary hematopoiesis
  • premature infant
  • recombinant erythropoietin

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Hematology
  • Oncology

Fingerprint Dive into the research topics of 'Late-onset blueberry muffin lesions following recombinant erythropoietin administration in a premature infant'. Together they form a unique fingerprint.

Cite this